PREDQ (Predictive Technology Group) Current Ratio: 0.29 (As of Mar. 2021)


What is Predictive Technology Group Current Ratio?

Predictive Technology Group PREDQ -90.00% Current Ratio is 0.29 as of Mar. 2021.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Predictive Technology Group's current ratio for the quarter that ended in Mar. 2021 was 0.29.

Predictive Technology Group has a current ratio of 0.29. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Predictive Technology Group has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Predictive Technology Group's Current Ratio or its related term are showing as below:

PREDQ's Current Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.885
* Ranked among companies with meaningful Current Ratio only.

Predictive Technology Group  (OTCPK:PREDQ) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Predictive Technology Group Current Ratio Related Terms


Predictive Technology Group Current Ratio Historical Data

* Premium members only.

The historical data trend for Predictive Technology Group's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Predictive Technology Group Current Ratio Chart

Predictive Technology Group Annual Data
Trend Aug06 Aug07 Jun16 Jun17 Jun18 Jun19 Jun20
Current Ratio
Get a 7-Day Free Trial 0.77 1.07 0.85 0.63 0.37

Predictive Technology Group Quarterly Data
Nov07 Feb08 May08 Jun16 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.37 0.36 0.22 0.29

PREDQ vs GLMD, RCAR, CKPT: Current Ratio Comparison

For the Biotechnology subindustry, Predictive Technology Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Technology Group Current Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Predictive Technology Group's Current Ratio distribution charts can be found below:

* The bar in red indicates where Predictive Technology Group's Current Ratio falls into.



Predictive Technology Group Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Predictive Technology Group's Current Ratio for the fiscal year that ended in Jun. 2020 is calculated as

Current Ratio (A: Jun. 2020 )=Total Current Assets (A: Jun. 2020 )/Total Current Liabilities (A: Jun. 2020 )
=7.704/20.836
=0.37

Predictive Technology Group's Current Ratio for the quarter that ended in Mar. 2021 is calculated as

Current Ratio (Q: Mar. 2021 )=Total Current Assets (Q: Mar. 2021 )/Total Current Liabilities (Q: Mar. 2021 )
=8.84/30.629
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.29 mean?
Predictive Technology Group (PREDQ) has a Current Ratio of 0.29 as of Mar. 2021.
Is Predictive Technology Group's Current Ratio too high?
Predictive Technology Group's current Current Ratio is 0.29. The Biotechnology industry median Current Ratio is 3.89. Predictive Technology Group's value of 0.29 is 92.5% below this industry median.
How does Predictive Technology Group's Current Ratio compare to GLMD and RCAR?
Predictive Technology Group's Current Ratio of 0.29 can be compared against companies in the Biotechnology industry. The industry median Current Ratio is 3.89. Predictive Technology Group's value of 0.29 is 92.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Predictive Technology Group's current Current Ratio of 0.29 is 92.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Predictive Technology Group's current Current Ratio is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predictive Technology Group stock overvalued right now?
Predictive Technology Group (PREDQ) has a current Current Ratio of 0.29. The current Current Ratio is 0.29 and 92.5% below the Biotechnology industry median of 3.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Predictive Technology Group (PREDQ), the current Current Ratio is 0.29 as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Predictive Technology Group Business Description

Address 2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.